Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Fennec Pharmaceuticals Inc. (T.FRX) had Free Cash Flow per Share of -0.22 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
-1.67M |
|
-- |
|
-- |
|
-- |
|
-1.16M |
|
-- |
|
-1.67M |
|
-1.67M |
|
-1.67M |
|
-1.67M |
|
-1.67M |
|
-1.67M |
|
-1.16M |
|
-1.14M |
|
27.58M |
|
27.58M |
|
-0.06 |
|
-0.06 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
66.64M |
|
-- |
|
-- |
|
-- |
|
75.08M |
|
-8.44M |
|
-8.44M |
|
-8.44M |
|
27.59M |
|
| Cash Flow Statement Financials | |
-6.20M |
|
-- |
|
0.52M |
|
38.25M |
|
32.56M |
|
-5.69M |
|
1.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.13 |
|
-- |
|
-- |
|
1.48 |
|
-3.07 |
|
95.74% |
|
-9.23% |
|
-9.23% |
|
-- |
|
-13.31% |
|
-13.31% |
|
-6.20M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
0.27 |
|
0.57 |
|
158.88 |
|
19.81% |
|
19.81% |
|
-2.51% |
|
-9.55% |
|
-0.31 |
|
|
Free Cash Flow per Share |
-0.22 |
-0.22 |
|